Haleon Plc Form 6-K Summary
Business Context and Reporting Period
This Form 6-K filing by Haleon Plc, a global leader in consumer health, covers the month of August 2025. The report specifically details a transaction in the company's own shares executed on August 20, 2025, under the second tranche of a share buyback programme announced on July 31, 2025.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on share repurchase activity. Key transaction data includes:
- Shares Purchased: 930,345 ordinary shares for cancellation.
- Price Range: Highest price paid was 367.00 pence; lowest was 360.90 pence.
- Average Price: Volume-weighted average price paid was 363.4411 pence per share.
- Share Capital: Post-settlement registered share capital is 8,970,871,750 ordinary shares of £0.01 each.
- Treasury Shares: 3,880,205 shares are held as treasury shares.
- Voting Rights: 8,966,991,545 ordinary shares carry voting rights.
Material Changes
The primary material change is the reduction of outstanding shares with voting rights due to the cancellation of 930,345 shares. This transaction is part of an ongoing capital return strategy initiated in late July 2025.
Guidance, Outlook, and Risks
The filing contains no financial guidance, forward-looking outlook, or discussion of risks and contingencies. It includes a standard disclaimer stating the announcement does not constitute an offer or solicitation of an offer for securities in any jurisdiction.
Investor Verification Checklist
- Verify the total number of shares purchased under the full second tranche of the buyback programme announced on July 31, 2025.
- Confirm the remaining authorization limit for the current share buyback programme.
- Review the full trade breakdown available via the London Stock Exchange link provided in the filing for granular execution details.
- Check subsequent filings for updates on the company's overall capital allocation strategy and treasury share holdings.